![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
UNC researchers develop potential universal coronavirus vaccine
Scientists at the University of North Carolina Gillings School of Global Public Health have developed...
mCureX and Samyang sign MoU for mRNA vaccine development
OliX Pharmaceuticals’ subsidiary mCureX has entered a memorandum of understanding (MoU) with Samyang Holdings to...
AGC Biologics Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its...
Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access ADUHELM
Following today’s U.S. FDA accelerated approval of ADUHELMTM as the first and only Alzheimer’s disease...
Centivax partners with US NMRC to study Covid-19 antibody
Centivax has signed a strategic collaboration with the US Naval Medical Research Center (NMRC) to...
Pacira BioSciences, Inc. partners with Ashfield Engage to deliver European commercial infrastructure
Ashfield Engage, part of UDG Healthcare plc, announced that it has been selected by US-based...
Engine Biosciences expands its digital drug discovery pipeline with $43M round
Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big...
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of...
Samsung Biologics , a leading global CDMO providing end-to-end contract development and manufacturing services, announced...
Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb
Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into...
Agilex Biolabs Toxicology Tapped for SARS-CoV-2 Vaccine Research
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said...